ASPEN PHARMACAR/ADR (OTCMKTS:APNHY) Reaches New 12-Month High at $8.86

ASPEN PHARMACAR/ADR (OTCMKTS:APNHY) reached a new 52-week high during trading on Wednesday . The company traded as high as $8.86 and last traded at $8.72, with a volume of 956 shares trading hands. The stock had previously closed at $8.37.

A number of equities research analysts recently commented on APNHY shares. ValuEngine lowered ASPEN PHARMACAR/ADR from a “sell” rating to a “strong sell” rating in a research report on Tuesday, March 17th. Zacks Investment Research raised ASPEN PHARMACAR/ADR from a “hold” rating to a “strong-buy” rating and set a $8.50 price target for the company in a research report on Wednesday, May 20th.

The stock has a 50-day moving average of $6.70 and a two-hundred day moving average of $7.15. The company has a market cap of $3.82 billion, a P/E ratio of 8.37 and a beta of 1.45.

About ASPEN PHARMACAR/ADR (OTCMKTS:APNHY)

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. The company offers various oral solid dose, liquids, semi-solids, steriles, biogicals, active pharmaceutical ingredients, and infant nutritional products.

Further Reading: Inflation

Receive News & Ratings for ASPEN PHARMACAR/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASPEN PHARMACAR/ADR and related companies with MarketBeat.com's FREE daily email newsletter.